How much funding has Valink Therapeutics raised?

Valink Therapeutics has raised $11.8M in total funding, most recently a Pre-Seed round.

Who are Valink Therapeutics's investors?

Valink Therapeutics's investors include LongeVC, Oxford Science Enterprises, Redalpine.

When was Valink Therapeutics founded?

Valink Therapeutics was founded in 2021.

Where is Valink Therapeutics headquartered?

Valink Therapeutics is headquartered in Boston, Massachusetts, United States.

What industry is Valink Therapeutics in?

Valink Therapeutics operates in Biotech, Drug Discovery, Healthcare, Therapeutics.

How many employees does Valink Therapeutics have?

Valink Therapeutics has 11-50 employees.

Valink Therapeutics

Discovering bispecific antibody drug-conjugates (BsADC) against cancer

Boston, United States · Founded 2021 · $11.8M raised

YC W21

Headquarters: Boston, Massachusetts
Employees: 11–50
Founded: 2021
Website: valinktx.com

Total Funding: $11.8M
Last Round: $11.8M Pre-SeedOct 2025
Rounds: 1

About

Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.

Summary

Valink Therapeutics is a Biotech company based in Boston, United States, founded in 2021. It has raised $11.8M in total across 1 round, most recently a $11.8M Pre-Seed round in Oct 2025. Investors include LongeVC, Oxford Science Enterprises and Redalpine.